News & Publications
On this page, you can find our publications in different disease areas and all the latest news and updates related to Porsolt.
We are at Biomed Israel together JANVIER LABS and our other French colleagues attending as part of Business France. Please stop by …
We will be exhibiting as part of the French delegation (Business France Israel booth #81) and please stop by to discuss your drug …
Our model recapitulates the pruritus (behavorial assessment of itching), epidermal hyperplasia and inflammation (histopathological analysis) characteristics of Atopic Dermatitis inflammatory skin disease. …
Porsolt is thrilled to already have our third paper published for this year: “Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical …
The upcoming Society of Toxicology meeting #SOT2022, is a good opportunity to highlight Porsolt’s Predictive Toxicology expertise for de-risking your drug development …
We are excited to release the 2022 Porsolt Interactive Catalog, detailing our established portfolio of services, and overflowing with new tests, models, …
Porsolt continues to play a significant role in research collaborations as demonstrated with the following paper just published by #Sunovion in the …
Hot off the press !! We are proud and excited to share this Nature press paper, just published by one of our …
Case study data for the validity of 2D and 3D screening assays during early stage drug development. Drug induced toxicity is responsible …
